Viferon gel 36000me/ml 10ml

Composition:
1 g of gel for external and local use contains the active substance: recombinant human Interferon alpha-2b 36,000 IU; excipients: alpha-tocopherol acetate 0.055 g, benzoic acid 0.00128 g, sodium tetraborate decahydrate 0.0018 g, methionine 0.0012 g, citric acid monohydrate 0.001 g, sodium chloride 0.004 g, human serum albumin solution 10% 0, 02 g, distilled glycerin (glycerol) 0.02 g, carmellose sodium 0.02 g, ethanol 95% 0.055 g, purified water to 1 g

Pharmacological properties
Interferon alpha-2b human recombinant has immunomodulatory, antiviral and anti-proliferative properties. Suppresses the replication of RNA and DNA viruses. The immunomodulating properties of interferon, such as the enhancement of the phagocytic activity of macrophages, the increase in the specific cytotoxicity of lymphocytes to target cells, determine its mediated antibacterial activity.

In the presence of antioxidants alpha-tocopherol acetate, citric and benzoic acids, the specific antiviral activity of interferon increases, and its immunomodulating action is enhanced, which makes it possible to increase the effectiveness of the body’s own immune response to infectious agents.
The drug has a pronounced local immunomodulatory effects and contributes to an increase in locally producedantibodies of the class of secretory IgA, preventing the fixation and reproduction of pathogenic microorganisms on the mucous membranes, which provides a preventive effect of the drug for the prevention of viral and other diseases.

Gel base provides a prolonged effect of the drug. Antioxidants that are part of the dosage form - alpha-tocopherol acetate, citric and benzoic acids have anti-inflammatory, membrane-stabilizing, regenerating properties, as well as help to preserve the biological activity of human interferon alpha-2b recombinant.

Indications for use
- in the complex therapy of ARVI, including influenza, frequent and long-term ARVI, including those complicated by bacterial infection;
- Prevention of acute respiratory viral infections, including influenza;
- in the complex therapy of recurrent stenosing laryngotracheobronchitis;
- prevention of recurrent stenosing laryngotracheobronchitis;
- in the complex therapy of acute and exacerbations of chronic recurrent herpetic infections of the skin and mucous membranes, including the urogenital herpes infection;
- In the treatment of herpetic cervicitis.

Contraindications
Hypersensitivity to any of the components of the drug.

Use during pregnancy and lactation
Pregnancy and lactation are not a contraindication to the use of the drug due to the very low absorption of the components. During lactation, do not apply to the nipple and areola area.

Dosage and administration
The drug is used externally and locally.

In the complex therapy of ARVI, including influenza, long-term and frequent ARVI, including those complicated by bacterial infection

Recurrent stenosing laryngotracheobronchitis

Acute and chronic recurrent herpetic infection
(at the first signs of the disease or during the precursors)

Herpetic cervicitis

SARS, including flu

Recurrent stenosing laryngotracheobronchitis

NOTE
The gel is applied to the mucous membrane of the nasal cavity after cleansing the nasal passages, on the surface of the tonsils - 30 minutes after eating. When applying the gel to the tonsils, do not touch the tonsils with a cotton swab, but only with a gel, while the gel flows down along the surface of the tonsil on its own. When applying the gel on the cervix, you must first remove the mucus and vaginal and cervical secretions with a cotton swab or gauze pad.
When applying the gel to the affected areas of the skin and mucous membranes, a thin film is formed in 30-40 minutes, to which the preparation is again applied.If desired, the film can be peeled off or washed off with water before reapplying the preparation.

Keep out of reach of children.

Side effect
In rare cases, allergic reactions may develop (skin rash, itching).
Interaction with other drugs
The drug is well combined with all the drugs used in the treatment of the above diseases (antibiotics, Chemotherapy , glucocorticosteroids).

Release form
Gel for external and local use, 36000 IU / g. At 12.0 g in aluminum tubes. 1 tube with instructions for use in a pack of cardboard.